Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Therese M Chapman

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Drugs|November 12, 2003
Lercanidipine : a review of its efficacy in the management of hypertensionLynne M Bang, Therese M Chapman, Karen L Goa
Drugs|September 3, 2004
Brivudin (bromovinyl deoxyuridine)Susan J Keam, Therese M Chapman, David P Figgitt
Drugs|August 15, 2006
VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseasesTherese M Chapman, Greg L Plosker, David P Figgitt
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 1, 2007
Spotlight on VSL#3 probiotic mixture in chronic inflammatory bowel diseasesTherese M Chapman, Greg L Plosker, David P Figgitt
Drugs|September 3, 2004
Fosamprenavir: a review of its use in the management of antiretroviral therapy-naive patients with HIV infectionTherese M Chapman, Greg L Plosker, Caroline M Perry
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Drugs|November 12, 2003
Lercanidipine : a review of its efficacy in the management of hypertensionLynne M Bang, Therese M Chapman, Karen L Goa
Drugs|September 3, 2004
Brivudin (bromovinyl deoxyuridine)Susan J Keam, Therese M Chapman, David P Figgitt
Drugs|August 15, 2006
VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseasesTherese M Chapman, Greg L Plosker, David P Figgitt
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 1, 2007
Spotlight on VSL#3 probiotic mixture in chronic inflammatory bowel diseasesTherese M Chapman, Greg L Plosker, David P Figgitt
Drugs|September 3, 2004
Fosamprenavir: a review of its use in the management of antiretroviral therapy-naive patients with HIV infectionTherese M Chapman, Greg L Plosker, Caroline M Perry
Pageof 2